Back to Agenda
Pharmacovigilance 2.0: Redesigning for the Future
Session Chair(s)
Annette S. Williams, MBA, RPH
Vice President, Pharmacovigilance, IQVIA, United States
Pharmacovigilance is a highly regulated environment with defined requirements for compliance and quality. The rapidly evolving world of artificial intelligence and machine learning has been applied to many industries with much success. How can these technological advances be applied to pharmacovigilance? Do they have a place in pharmacovigilance? Can they truly deliver the 3 C's: control, consistency, and cost savings? Real world examples will presented where these innovations are already in use, the difficulties encountered, and how organizations are harnessing the art of the possible.
Learning Objective : Describe available automation and artificial intelligence technologies; Discuss where these innovations are being applied; Describe tools to assess organizational readiness for this major redesign.
Speaker(s)
Pharmacovigilance and the Promise of Artificial Intelligence
Vice President, Pharmacovigilance, IQVIA, United States
Information Technology Innovation in R&D: One Company's Journey, So Far
Director, Safety Systems Management, Merck & Co., Inc., United States
Unlocking Incredible Value in Safety Databases Together: The Platform Opportunity
Vice President, Safety Operations, AbbVie, Inc., United States
Pharmacovigilance Innovation
Principal, Deloitte, United States
Have an account?